Literature DB >> 19499

Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma.

N E Stathakis, M W Mosesson.   

Abstract

Fibrinogen and the cold-insoluble globulin of plasma (CIg) are the main protein components of the heparin-precipitable fraction of normal plasma. The interactions among these proteins and heparin were examined. Heparin formed a cold-precipitable complex with purified CIg or with mixtures of CIg and fibrinogen but not with purified fibrinogen alone. Cryoprecipitation was augmented by addition of Ca(++) or by selection of optimal heparin levels; it was reduced or even abolished by raising the ionic strength or pH or both, or by raising the heparin concentration above that for maximum precipitation of CIg. Fibrinogen reduced the threshold for heparin-induced CIg cryoprecipitation and, by coprecipitating with heparin and CIg, increased the amount of precipitate that formed. In contrast to the heparin-precipitable fraction of normal plasma which contained both fibrinogen and CIg, that from a patient with congenital afibrinogenemia contained CIg but lacked fibrinogen. Normal plasma depleted of CIg by immunoabsorption failed to form a heparin-induced cryoprecipitate. Thus, CIg is essential for heparin-induced cryoprecipitation to occur. Fibrinogen, as assessed by chromatographic experiments with heparin-Sepharose columns, had a considerably lower binding affinity for heparin than did CIg, suggesting that it participates in precipitate formation mainly, if not entirely, by virtue of its affinity for CIg. The region of the fibrinogen molecule accounting for its precipitation with CIg appears to be localized in the carboxy-terminal segment of the Aalpha-chain; fibrinogen subfractions lacking this region failed to augment cryoprecipitation of heparin-CIg mixtures and, even though such species were present in normal plasma, they failed to coprecipitate in the heparin-induced complex.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19499      PMCID: PMC372434          DOI: 10.1172/JCI108840

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

Review 1.  Interaction between proteins and glycosaminoglycans.

Authors:  T C Laurent
Journal:  Fed Proc       Date:  1977-01

2.  The cold-insoluble globulin of human plasma: studies of its essential structural features.

Authors:  M W Mosesson; A B Chen; R M Huseby
Journal:  Biochim Biophys Acta       Date:  1975-04-29

3.  Cryofibrinogen in the plasma of patients with skin ulcerative lesions on the legs: a complex of fibrinogen and cold insoluble globulin.

Authors:  M Matsuda; T Saida; R Hasegawa
Journal:  Thromb Res       Date:  1976-12       Impact factor: 3.944

4.  Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.

Authors:  L O Andersson; T W Barrowcliffe; E Holmer; E A Johnson; G E Sims
Journal:  Thromb Res       Date:  1976-12       Impact factor: 3.944

5.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

6.  Heparin precipitable fraction (HPF) from dermatoligical patients. I. Characterization of the thrombin-clottable protein.

Authors:  O Fyrand; N O Solum; P Kierulf
Journal:  Thromb Res       Date:  1976-01       Impact factor: 3.944

Review 7.  Heparin assay methods for control of in vivo heparin effects.

Authors:  H C Godal
Journal:  Thromb Diath Haemorrh       Date:  1975-02-28

8.  Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor.

Authors:  D F Mosher
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

9.  Action of heparin on thrombin-antithrombin reaction.

Authors:  R Machovich; G Blaskó; L A Pálos
Journal:  Biochim Biophys Acta       Date:  1975-01-30

10.  Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin.

Authors:  E Ruoslahti; A Vaheri
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  57 in total

1.  Interaction of the fibronectin COOH-terminal Fib-2 regions with fibrin: further characterization and localization of the Fib-2-binding sites.

Authors:  Evgeny Makogonenko; Kenneth C Ingham; Leonid Medved
Journal:  Biochemistry       Date:  2007-04-11       Impact factor: 3.162

2.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Ail protein binds ninth type III fibronectin repeat (9FNIII) within central 120-kDa region of fibronectin to facilitate cell binding by Yersinia pestis.

Authors:  Tiffany M Tsang; Douglas S Annis; Malte Kronshage; Jesse T Fenno; Lisa D Usselman; Deane F Mosher; Eric S Krukonis
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

4.  Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.

Authors:  J S Coppock; D L Scott; S D Carter; T M Moreland; M W Robinson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

5.  Phagocytosis-promoting activity of avian plasma and fibroblastic cell surface fibronectins.

Authors:  D Marquette; J Molnar; K Yamada; D Schlesinger; S Darby; P Van Alten
Journal:  Mol Cell Biochem       Date:  1981-05-26       Impact factor: 3.396

6.  Plasma fibronectin in normal subjects and in various disease states.

Authors:  N E Stathakis; A Fountas; E Tsianos
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

7.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

8.  Diagnostic relevance of fibronectin in cryoprecipitates.

Authors:  M W Robinson; K W Walton; D G Scott; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  Fibronectin--mediator between cells and connective tissue.

Authors:  H Hörmann
Journal:  Klin Wochenschr       Date:  1982-10-15

10.  Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.